Pharmaceutical company
AstraZeneca has experienced a significant deterioration in its relationship with the British government following disputes linked to its
COVID-19
vaccine rollout.
Sources suggest frustrations stem from legal, regulatory, and political disagreements that have driven a wedge between the once close partners.
The falling out marks a critical shift in the UK's post-pandemic pharmaceutical landscape.